Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
CMS Emails ‘Muddy The Waters,’ Sandoz Claims; Drugs Are ‘Quintessential Generics’
Sandoz has fired a defensive shot in a US court against the potential that it may have to fork up higher rebates for two of its drugs via the Centers for Medicare & Medicaid Services’ Medicaid drug rebate program – six years after the suggestion was first made.
